Functional Genomics and Molecular Imaging of Liver Disease and Cancer

[18F]Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling

S. Kwee, Miles M Sato, Y. Kuang, et al.. (2017). Molecular Imaging and Biology. Cited 22 times. https://doi.org/10.1007/s11307-016-1020-3

Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort

Scott T. Nishioka, Miles M Sato, L. Wong, et al.. (2018). Hepatoma research. Cited 19 times. https://doi.org/10.20517/2394-5079.2017.46

Transcriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma.

S. Kwee, M. Tiirikainen, Miles M Sato, et al.. (2019). Cancer research. Cited 15 times. https://doi.org/10.1158/0008-5472.CAN-18-3837

PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer.

S. Kwee, L. Wong, Owen Chan, et al.. (2018). Radiology. Cited 11 times. https://doi.org/10.1148/radiol.2018171333

Metabolic positron emission tomography imaging of cancer: Pairing lipid metabolism with glycolysis

S. Kwee, J. Lim. (2016). World Journal of Radiology. Cited 6 times. https://doi.org/10.4329/wjr.v8.i11.851